Please complete the CAPTCHA to continue
@centurytel.net
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Mika Nishimura is listed as Global Commercialization Leader | Independent Director | Venture Investor at Gilde Healthcare, based in San Francisco Bay Area, United States, United States. AeroLeads shows a work email signal at centurytel.net and a matched LinkedIn profile for Mika Nishimura.
Mika Nishimura previously worked as Operational Partner at Gilde Healthcare and Independent Director, Audit, Nominating, and Comp Committees. Healthcare Compliance Committee Chair at Hoya. Mika Nishimura holds Master Of Business Administration - Mba from Harvard Business School.
This section adds company-level context without repeating Mika Nishimura's masked contact details.
AeroLeads found 1 current-domain work email signal for Mika Nishimura. Compare company email patterns before reaching out.
As a Global Commercialization Executive, I am known for conceiving, planning, and launching disruptive medical technologies across global markets from inception to scale, consistently exceeding corporate objectives and financial goals.A trusted advisor and an independent board director for companies looking to grow their international business, I successfully shepherd organizations, from small early-clinical-stage private ventures to global commercial enterprises across a spectrum of technologies.My teams thrive within the culture of shared vision, battlefield experience, and accountability I promote. Additionally, I work proactively with the management to realign organizational structures based on the ever-changing landscape of opportunities and occasionally adverse market conditions.How do I advise my teams to succeed?STRATEGIC EXECUTION: My value is identifying expansion opportunities to increase enterprise value, helping management design strategic road maps grounded in understanding market dynamics, regulatory environments, and customer insights, and setting realistic but challenging execution plans. GLOBAL COMMERCIAL LEADERSHIP: I have been exceptionally resourceful in leveraging my extensive network across the med-tech industry to recruit exceptional talent globally. Additionally, I assist management in actively engaging with strategic partners, critical societies, prominent physicians, advisors, and advocacy groups to enhance organizational visibility, helping to ensure commercial success.FINANCIAL & RISK MANAGEMENT: Working with the company leadership, my collaborative style focuses on managing potential exposures. Additionally, I instill a culture of integrity in my team by providing the necessary tools and training. ORGANIZATIONAL DEVELOPMENT: I foster a culture of shared vision, leveraging industry experience and personal/team accountability, coupled with an innate ability to identify, develop, and mentor diverse and inclusive executive talent. Currently, I am looking to add one more board director position, preferably with a late-stage private company.
Listed skills include Start Ups, Medical Devices, Cross Functional Team Leadership, Business Development, and 18 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Utrecht, NL
Since 2011, I have been the West Coast operational partner with this trans-Atlantic life-science venture fund with $2 billion under management and a new $800 million fund. As an integral member of the investment team, I conduct due diligence and generate deal flow in both the US and in Europe. Because of my extensive background in global commercialization.
Tacoma, Washington, US
HOYA (Tokyo Stock Exchange Prime: 7741) constantly strives to create new value through innovation based on its advanced optics technologies.
Madison, WI, US
Accuray (Nasdaq: ARAY) is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible.
Santa Clara, California, US
SI-BONE (Nasdaq: SIBN) is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System.
Snailwell, Cambridgeshire, GB
Tristel, plc is a UK publicly listed company and a global leader in high-level medical device decontamination and disinfection.
Tel Aviv, IL
MobileODT is a commercial-stage venture-backed company with an AI clinical decision support technology to assess cervical cancer.
Marlborough, MA, US
I joined nVision Medical which was an 8-person clinical-stage company focused on early detection of ovarian cancer to help the CEO raise Series B financing. In less than 2 years, the company was acquired by Boston Scientific for $275 million in the largest transaction in women's health in recent years.►For a pre-commercial-stage company, it was important.
I was brought into the company by the board to partner with the CEO to create the vision for and successfully commercialize a first of a kind AI-based embryo assessment technology (Eeva) for IVF procedures. ► We launched Eeva in a few select international markets after based on ease of market access, the potential market size, similarities to the US market.
I founded The BLG Group, a consulting partnership to help medical device companies identify and attract investors and pursue growth opportunities. Over the years, we completed over 40 client projects, including several multi-year engagements across 14 distinct clinical/technology segments ranging from aesthetics to pharmacy automation to metabolic syndrome.
At ev3, I persuaded the CEO to invest in emerging markets by presenting a compelling and robust business plan. We built commercial infrastructure across 35 markets to sell over 400 SKUs across peripheral and neurovascular product lines. In less than 5 years, we grew the revenue from $500K to $60 million run-rate, exceeding revenue target in 16 out of 19.
I spearheaded international marketing in both developed and emerging markets at the Vascular Intervention Division. I transitioned the international sales strategy from distributors to direct operations in key strategic markets including DACHS, France, UK, Benelux, Japan, and Australia, resulting in >100% increase in revenue and >30% improvement in market.
Boston, MA, US
As a strategy consultant, I executed over 20 M&A advisory engagements across a variety of industries from healthcare, consumer products, and an airline. I counseled clients on the fit between the proposed deal and their strategic objectives and provided recommendations on realistic valuation.
Quick answers generated from the profile data available on this page.
Mika Nishimura works for Gilde Healthcare.
Mika Nishimura is listed as Global Commercialization Leader | Independent Director | Venture Investor at Gilde Healthcare.
AeroLeads has found 1 work email signal at @centurytel.net for Mika Nishimura at Gilde Healthcare.
Mika Nishimura is based in San Francisco Bay Area, United States, United States while working with Gilde Healthcare.
Mika Nishimura has worked for Gilde Healthcare, Hoya, Accuray, Si-Bone, and Tristel Global.
You can use AeroLeads to view verified contact signals for Mika Nishimura at Gilde Healthcare, including work email, phone, and LinkedIn data when available.
Mika Nishimura holds Master Of Business Administration - Mba from Harvard Business School.
Mika Nishimura is listed with skills including Start Ups, Medical Devices, Cross Functional Team Leadership, Business Development, Business Strategy, Strategy, Management, and Marketing Strategy.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts